FDA Approved: DEXLANSOPRAZOLE — Supplemental Application (ENDO USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for dexlansoprazole submitted by ENDO USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)

Snippet

SUPPL AP for DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)